BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1750421)

  • 1. Biochemical markers of bone turnover: methodology and clinical use in osteoporosis.
    Delmas PD
    Am J Med; 1991 Nov; 91(5B):59S-63S. PubMed ID: 1750421
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical markers of bone turnover in diagnosis and assessment of therapy.
    Riis BJ
    Am J Med; 1991 Nov; 91(5B):64S-68S. PubMed ID: 1750422
    [No Abstract]   [Full Text] [Related]  

  • 3. What do we know about biochemical bone markers?
    Delmas PD
    Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):817-30. PubMed ID: 1822819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological variation of biochemical bone markers.
    Jensen JE; Sørensen HA; Kollerup G; Jensen LB; Sørensen OH
    Scand J Clin Lab Invest Suppl; 1994; 219():36-9. PubMed ID: 7701238
    [No Abstract]   [Full Text] [Related]  

  • 5. The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice?
    Blumsohn A; Eastell R
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():449-59. PubMed ID: 9293302
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical markers of bone turnover: an update.
    van Daele PL; Birkenhäger JC; Pols HA
    Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers of bone turnover.
    Fraher LJ
    Clin Biochem; 1993 Dec; 26(6):431-2. PubMed ID: 8124854
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory diagnosis of osteoporosis].
    Schmolke B
    Orthopade; 2001 Jul; 30(7):425-36. PubMed ID: 11515180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
    Ofluoglu D; Karadag-Saygi E; Canbulat C; Gunduz OH; Kul-Panza E; Akyuz G
    Rheumatol Int; 2006 Feb; 26(4):288-91. PubMed ID: 15875189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone markers: biochemical and clinical significance.
    Lello S; Paoletti AM; Migliaccio S; Melis GB
    Aging Clin Exp Res; 2004 Jun; 16 Suppl(3):33-6. PubMed ID: 15506699
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical markers of bone turnover. I: Theoretical considerations and clinical use in osteoporosis.
    Delmas PD
    Am J Med; 1993 Nov; 95(5A):11S-16S. PubMed ID: 8256787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: physical and biochemical characteristics.
    Pouillès JM; Trémollieres FA; Ribot C
    Osteoporos Int; 2006 Feb; 17(2):193-200. PubMed ID: 16021526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis.
    Pietschmann P; Resch H; Krexner E; Woloszczuk W; Willvonseder R
    Acta Med Austriaca; 1991; 18(5):114-6. PubMed ID: 1796722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using biochemical bone markers.
    Chapman B
    CAP Today; 1997 Feb; 11(2):1, 30-2, 36. PubMed ID: 10166427
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
    Mango D; Ricci S; Manna P; Natili G; Dell'Acqua S
    Minerva Endocrinol; 1993 Sep; 18(3):115-21. PubMed ID: 8183178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
    Weaver CM; Peacock M; Martin BR; McCabe GP; Zhao J; Smith DL; Wastney ME
    J Bone Miner Res; 1997 Oct; 12(10):1714-20. PubMed ID: 9333133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.